Found 6 matching trials
ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease
PHASE2The purpose of this study is to evaluate the long-term safety and tolerabil...
Location
Banner Alzheimer's Institute
A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
PHASE2To evaluate the safety and tolerability of ELND005 treatment with up to 36 ...
Location
TransitionTIL Investigational Site
Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder
PHASE2The primary purpose of this study is to determine whether ELND005 is effect...
Location
Elan Investigational Site
Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
PHASE2The primary purpose of this study is to determine whether ELND005 is effect...
Location
TransitionTIL Investigational Site
A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
PHASE2This is a prospective, randomized, double-blind, placebo-controlled, parall...
Location
University of California, San Diego
ELND005 in Patients With Mild to Moderate Alzheimer's Disease
PHASE2The purpose of this study is to evaluate the dose-related safety and effica...
Location
Banner Alzheimer's Institute